Pharmacological Activity of a Sulfobisanion in Models of Experimental Dyslipoproteinemia and Atherosclerosis

Author： Okunevich I.   Khnychenko L.   Sapronov N.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.47, Iss.7, 2013-10, pp. : 374-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

By De Vries P.   Villalon C.M.   Saxena P.R.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 61-74

Elsevier

Access to resources Recommend Favorite

Pharmacological Regulation of the Cough Reflex—from Experimental Models to Antitussive Effects in Man

By   Fuller R.W.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 4, 1999-08 ,pp. : 215-228

Academic Press

Access to resources Recommend Favorite

Apoptosis in atherosclerosis: pathological and pharmacological implications

By Guevara N.V.   Chan L.  

Pharmacological Research, Vol. 44, Iss. 2, 2001-08 ,pp. : 59-71

Academic Press

Access to resources Recommend Favorite

Genetics of Atherosclerosis in Murine Models

By  

Current Drug Targets, Vol. 8, Iss. 11, 2007-11 ,pp. : 1161-1171

Bentham Science Publishers

Access to resources Recommend Favorite

Heparin: Pharmacological Potentials from Atherosclerosis to Asthma

By Ragazzi E.   Chinellato A.  

General Pharmacology, Vol. 26, Iss. 4, 1995-07 ,pp. : 697-701

Elsevier

Access to resources Recommend Favorite